Research News and Research

RSS

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced it has reached the target enrollment for the double-blind placebo-controlled phase III program of XIAFLEX for the treatment of Peyronie's disease.

9 Mar 2011

Camp STAR to offer evidence-based therapy for children with ADHD

Camp STAR, the Chicago area's only summer camp offering evidence-based therapy for children with Attention Deficit/Hyperactivity Disorder and other behavioral, emotional and social difficulties, begins its fourth season in June.

9 Mar 2011

Roundup: Legislatures pressured on health cuts, malpractice laws; Mass. Blue Cross board salaries; pension costs

This week, the Assembly and Senate will debate the final package of budget reductions. Among the $6 billion in health-related cuts is the elimination of the Maddy Fund, a $55 million attempt to reimburse emergency departments for indigent care.

9 Mar 2011

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

The U.S. Food and Drug Administration today approved Benlysta to treat patients with active, autoantibody-positive lupus who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.

9 Mar 2011

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

ERYtech Pharma announces the early completion of the enrollment and safety follow-up a Phase II clinical trial for GRASPA. This open-labeled trial introduced GRASPA in a first-line treatment for Acute Lymphoblastic Leukemia in patients older than 55 years.

9 Mar 2011

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.

9 Mar 2011

Study finds passive smoking increases risk of still birth by 23%

Pregnant non-smokers who breathe in the second-hand smoke of other people are at an increased risk of delivering stillborn babies or babies with defects, a study led by researchers at The University of Nottingham has found.

9 Mar 2011

Economic benefits of enabling people to age at home

There are a number of studies that look at the economics of technologies to enable people to age at home rather than in some other kind of accommodation. In 2010, CSES contributed an economic analysis for the ATSE report written by Greg Tegart drawing in part on these studies and using Australian data on demographic trends and healthcare costs.

9 Mar 2011

M-3 Information introduces new behavioral health website to improve quality of care

The evidenced-based behavioral health portal, allows patients to take the screen using the Apple iPad; provides the clinician immediate clinical decision support at the point of care.

9 Mar 2011

Fluidigm fourth quarter revenue increases to $10.4 million

Fluidigm Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2010.

9 Mar 2011

MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting

A year after its launch, the first dermatologist-driven company dedicated to primary skin cancer protection and prevention introduced its newest solar protection product -- a much-anticipated tinted mineral gel sunscreen – at the 2011 AAD meeting in New Orleans.

9 Mar 2011

U.S. Bank introduces two enhanced offerings for healthcare providers

U.S. Bank's healthcare payments division today introduced two enhanced offerings—Payment Navigator and Payment Consolidator—that help healthcare providers improve revenue cycles and streamline complex payment processes, at a time when providers face unprecedented challenges getting paid for their services.

9 Mar 2011

Research shows how tubercle bacterium manages to survive inside body's macrophage cells

Tuberculosis kills two million people each year and is once again gaining ground also in Sweden and other Western countries. Researchers at Linköping University in Sweden are now presenting new findings that show how the tubercle bacterium manages to survive inside the body's macrophage cells in order eventually to blow them up and spread their infection.

9 Mar 2011

Oral magnesium oxide is a safe treatment for children with chronic constipation

Magnesium-containing cathartics are commonly used to treat chronic constipation. Although hypermagnesemia is a rare clinical condition, it can occur as a side effect of increased intake of magnesium salts.

9 Mar 2011

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

RainDance Technologies, Inc., and 454 Life Sciences, a Roche Company, today announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the simple and cost-effective investigation of drug absorption, distribution, metabolism, and excretion (ADME).

9 Mar 2011

The American Journal of Medicine focuses on the continuing healthcare reform debate

As the debate about healthcare in the United States rages, four insightful articles in the March 2011 issue of The American Journal of Medicine strive to add reasoned arguments and empirical research findings to the dialog.

9 Mar 2011

Variation in exposure to sunlight may affect sensitivity of individuals to drugs

A study from the Swedish medical university Karolinska Institutet has shown that the body's ability to break down medicines may be closely related to exposure to sunlight, and thus may vary with the seasons.

9 Mar 2011

Study supports DNA mismatch repair test for bowel cancer

Bowel cancer patients whose tumors contain defects in specific DNA repair systems are much less likely to experience tumour recurrence post surgery, results from a major clinical study have demonstrated.

9 Mar 2011

Geospiza, NuGEN partner to develop seamless next-generation sequencing workflow

Geospiza, Inc., the market leading developer of genetic analysis software, and NuGEN Technologies, Inc., the leader in sample preparation solutions for clinical samples, today announced a co-marketing agreement to develop a seamless next-generation sequencing workflow to accelerate discoveries for large disease research studies.

9 Mar 2011

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

Cardium Therapeutics today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study.

9 Mar 2011

Research News and Research

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Camp STAR to offer evidence-based therapy for children with ADHD

Roundup: Legislatures pressured on health cuts, malpractice laws; Mass. Blue Cross board salaries; pension costs

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Study finds passive smoking increases risk of still birth by 23%

Economic benefits of enabling people to age at home

M-3 Information introduces new behavioral health website to improve quality of care

Fluidigm fourth quarter revenue increases to $10.4 million

MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting

U.S. Bank introduces two enhanced offerings for healthcare providers

Research shows how tubercle bacterium manages to survive inside body's macrophage cells

Oral magnesium oxide is a safe treatment for children with chronic constipation

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

The American Journal of Medicine focuses on the continuing healthcare reform debate

Variation in exposure to sunlight may affect sensitivity of individuals to drugs

Study supports DNA mismatch repair test for bowel cancer

Geospiza, NuGEN partner to develop seamless next-generation sequencing workflow

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News